Addressing the treatment gap for patients with relapsed/refractory primary systemic AL amyloidosis: TOURMALINE-AL1 trial results
Addressing the treatment gap for patients with relapsed/refractory primary systemic AL amyloidosis: TOURMALINE-AL1 trial results
Carfilzomib, lenalidomide and dexamethasone in newly diagnosed multiple myeloma
Challenges and importance of long-term treatment for newly diagnosed multiple myeloma patients; community-based trial data
Novel multi-antigen targeted CAR-NK cell for the treatment of B cell malignancies
Multiple myeloma: Anti-BCMA BiTE AMG 701 shows preclinical promise
Evaluating emerging mutations in patients with acute myeloid leukaemia who relapsed while receiving gilteritinib therapy in the ADMIRAL trial
Maintenance decitabine after intensive therapy for AML in older FLT3-ITD-negative patients
Bispecific CAR T-cell therapy as treatment for hard to treat multiple myeloma
Mosunetuzumab induces complete remissions in poor prognosis non-Hodgkin lymphoma patients
Dual-targeted antibody mosunetuzumab elicits durable responses in poor-prognosis non-Hodgkin Lymphoma patients
CAR T-cell therapy in hard-to-treat multiple myeloma produces sustained remissions
City of Hope and ACCC: Current projects and future directions